Drug-induced diseases in otolaryngology – causes, clinical signs, treatment

• Authors: Jarosław Woroń , Dariusz Jurkiewicz , Piotr Rapiejko , Barbara Lorkowska- Zawicka , Radosław Tymiński , Jerzy Wordliczek

Abstracts

EN

Introduction: In the daily practice of an otolaryngologist, we encounter cases where the symptoms are not the result of disease but result from pharmacotherapy. In the case of symptoms such as hearing loss, tinnitus, or dizziness, polytherapy may be used as the basis for their occurrence, which, due to the lack of rationality in combining drugs, leads to symptoms that the patient and the doctor very often interpret as a new disease syndrome.
Aim: The aim of the study is to show and to raise awareness of the fact that the symptoms of hearing organ impairment are frequently drug-related and only a modification of the currently used pharmacotherapy is a rational procedure in such cases.
Material: This paper describes 30 cases who developed side effects of polypharmacy in the form of hearing disorders, dizziness, and tinnitus. The causes of drug-related complications were discussed, as well as effective methods of their prevention.

Keywords

EN

drug interactions; otolaryngology; pharmacotherapy; side effects

• Publisher: Index Copernicus International
• Journal: Polish Journal of Otolaryngology
• Year: 2021
• Volume: 75
• Issue: 5
• Pages: 9-15

Dates

published

2021

Contributors

author

Jarosław Woroń

• Department of Clinical Pharmacology, Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College in Krakow, Poland
• The University Hospital in Krakow, Anaesthesiology and Intensive Care Clinical Department, Poland

author

Dariusz Jurkiewicz

• Department of Otolaryngology and Laryngological Oncology with the Clinical Department of Cranio-Maxillofacial Surgery, Military Medical Institute in Warsaw, Poland

author

Piotr Rapiejko

• Department of Otolaryngology and Laryngological Oncology with the Clinical Department of Cranio-Maxillofacial Surgery, Military Medical Institute in Warsaw, Poland

author

Barbara Lorkowska- Zawicka

• Department of Clinical Pharmacology, Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College in Krakow, Poland
• The University Hospital in Krakow, Otolaryngology Clinical Department, Poland

author

Radosław Tymiński

• Radoslaw Tyminski Law Office, Poland

author

Jerzy Wordliczek

• The University Hospital in Krakow, Anaesthesiology and Intensive Care Clinical Department, Poland
• Clinic of Intensive Interdisciplinary Therapy, Jagiellonian University Medical College in Krakow, Poland

Identifiers

DOI

10.5604/01.3001.0014.7445

Biblioteka Nauki

23203210